Home > Financial Ratios > HESTER BIOSCIENCES

HESTER BIOSCIENCES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for HESTER BIOSCIENCES
Please provide your vote to see the results

HESTER BIOSCIENCES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 1.06-2.23-10.800.5218.74

What is the latest Core EBITDA Growth ratio of HESTER BIOSCIENCES ?

The latest Core EBITDA Growth ratio of HESTER BIOSCIENCES is 1.06 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar20251.06
Mar2024-2.23
Mar2023-10.80
Mar20220.52
Mar202118.74

How is Core EBITDA Growth of HESTER BIOSCIENCES Trending?

Years Core EBITDA Growth % Change
Mar2025 1.06
Positive
Mar2024 -2.23
Negative
Mar2023 -10.8
Negative
Mar2022 0.52
-97.23
Mar2021 18.74 -

Other Financial Ratios of HESTER BIOSCIENCES


Compare Core EBITDA Growth ratio of peers of HESTER BIOSCIENCES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
HESTER BIOSCIENCES ₹1,261.7 Cr -6.8% -6.8% -33.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,019.0 Cr -3.5% -5.4% -3.2% Stock Analytics
DIVIS LABORATORIES ₹168,752.0 Cr -3.6% 0.2% 11.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,542.0 Cr -0.5% 5.9% 20.3% Stock Analytics
CIPLA ₹115,883.0 Cr -1.8% -4.8% -1.5% Stock Analytics
DR REDDYS LABORATORIES ₹99,024.7 Cr -1.7% -7.3% -12.1% Stock Analytics


HESTER BIOSCIENCES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
HESTER BIOSCIENCES

-6.8%

-6.8%

-33.4%

SENSEX

-1.9%

-2.2%

7.4%


You may also like the below Video Courses